CML-313 Post Hoc Analysis of Patient Responses by T315I Mutation Status From the 3-Year Update of the OPTIC Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib Article Swipe
Jorge E. Cortés
,
Michael W. Deininger
,
Elza Lomaia
,
Beatriz Moiraghi
,
Maria Undurraga Sutton
,
Carolina Pavlovsky
,
Charles Chuah
,
Tomasz Sacha
,
Jeffrey H. Lipton
,
James McCloskey
,
Philippe Rousselot
,
Gianantonio Rosti
,
Hugues de Lavallade
,
Christine Rojas
,
Anna Turkina
,
Moshe Talpaz
,
Michael J. Mauro
,
Vickie Lu
,
Alexander Vorog
,
Jane F. Apperley
·
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/s2152-2650(23)01134-5
YOU?
·
· 2023
· Open Access
·
· DOI: https://doi.org/10.1016/s2152-2650(23)01134-5
Related Topics
Concepts
Ponatinib
Medicine
Post hoc
Post-hoc analysis
Mutation
Oncology
Internal medicine
Genetics
Biology
Gene
Receptor
Tyrosine kinase
Dasatinib
Metadata
- Type
- article
- Language
- en
- Landing Page
- https://doi.org/10.1016/s2152-2650(23)01134-5
- https://doi.org/10.1016/s2152-2650(23)01134-5
- OA Status
- bronze
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W4386282375
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W4386282375Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1016/s2152-2650(23)01134-5Digital Object Identifier
- Title
-
CML-313 Post Hoc Analysis of Patient Responses by T315I Mutation Status From the 3-Year Update of the OPTIC Trial: A Dose-Optimization Study of 3 Starting Doses of PonatinibWork title
- Type
-
articleOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2023Year of publication
- Publication date
-
2023-08-30Full publication date if available
- Authors
-
Jorge E. Cortés, Michael W. Deininger, Elza Lomaia, Beatriz Moiraghi, Maria Undurraga Sutton, Carolina Pavlovsky, Charles Chuah, Tomasz Sacha, Jeffrey H. Lipton, James McCloskey, Philippe Rousselot, Gianantonio Rosti, Hugues de Lavallade, Christine Rojas, Anna Turkina, Moshe Talpaz, Michael J. Mauro, Vickie Lu, Alexander Vorog, Jane F. ApperleyList of authors in order
- Landing page
-
https://doi.org/10.1016/s2152-2650(23)01134-5Publisher landing page
- PDF URL
-
https://doi.org/10.1016/s2152-2650(23)01134-5Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://doi.org/10.1016/s2152-2650(23)01134-5Direct OA link when available
- Concepts
-
Ponatinib, Medicine, Post hoc, Post-hoc analysis, Mutation, Oncology, Internal medicine, Genetics, Biology, Gene, Receptor, Tyrosine kinase, DasatinibTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
0Total citation count in OpenAlex
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W4386282375 |
|---|---|
| doi | https://doi.org/10.1016/s2152-2650(23)01134-5 |
| ids.doi | https://doi.org/10.1016/s2152-2650(23)01134-5 |
| ids.openalex | https://openalex.org/W4386282375 |
| fwci | 0.0 |
| type | article |
| title | CML-313 Post Hoc Analysis of Patient Responses by T315I Mutation Status From the 3-Year Update of the OPTIC Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib |
| biblio.issue | |
| biblio.volume | 23 |
| biblio.last_page | S338 |
| biblio.first_page | S338 |
| topics[0].id | https://openalex.org/T11157 |
| topics[0].field.id | https://openalex.org/fields/27 |
| topics[0].field.display_name | Medicine |
| topics[0].score | 0.9973999857902527 |
| topics[0].domain.id | https://openalex.org/domains/4 |
| topics[0].domain.display_name | Health Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2716 |
| topics[0].subfield.display_name | Genetics |
| topics[0].display_name | Chronic Lymphocytic Leukemia Research |
| topics[1].id | https://openalex.org/T11215 |
| topics[1].field.id | https://openalex.org/fields/27 |
| topics[1].field.display_name | Medicine |
| topics[1].score | 0.9902999997138977 |
| topics[1].domain.id | https://openalex.org/domains/4 |
| topics[1].domain.display_name | Health Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2720 |
| topics[1].subfield.display_name | Hematology |
| topics[1].display_name | Chronic Myeloid Leukemia Treatments |
| topics[2].id | https://openalex.org/T12829 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9769999980926514 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2740 |
| topics[2].subfield.display_name | Pulmonary and Respiratory Medicine |
| topics[2].display_name | Advanced Breast Cancer Therapies |
| is_xpac | False |
| apc_list.value | 3670 |
| apc_list.currency | USD |
| apc_list.value_usd | 3670 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C2780381907 |
| concepts[0].level | 5 |
| concepts[0].score | 0.8121091723442078 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q198728 |
| concepts[0].display_name | Ponatinib |
| concepts[1].id | https://openalex.org/C71924100 |
| concepts[1].level | 0 |
| concepts[1].score | 0.5685549974441528 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[1].display_name | Medicine |
| concepts[2].id | https://openalex.org/C2992886853 |
| concepts[2].level | 2 |
| concepts[2].score | 0.5382961630821228 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q18381816 |
| concepts[2].display_name | Post hoc |
| concepts[3].id | https://openalex.org/C67761136 |
| concepts[3].level | 2 |
| concepts[3].score | 0.5175687670707703 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q2105849 |
| concepts[3].display_name | Post-hoc analysis |
| concepts[4].id | https://openalex.org/C501734568 |
| concepts[4].level | 3 |
| concepts[4].score | 0.44518938660621643 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q42918 |
| concepts[4].display_name | Mutation |
| concepts[5].id | https://openalex.org/C143998085 |
| concepts[5].level | 1 |
| concepts[5].score | 0.36307066679000854 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q162555 |
| concepts[5].display_name | Oncology |
| concepts[6].id | https://openalex.org/C126322002 |
| concepts[6].level | 1 |
| concepts[6].score | 0.32894736528396606 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[6].display_name | Internal medicine |
| concepts[7].id | https://openalex.org/C54355233 |
| concepts[7].level | 1 |
| concepts[7].score | 0.20875108242034912 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q7162 |
| concepts[7].display_name | Genetics |
| concepts[8].id | https://openalex.org/C86803240 |
| concepts[8].level | 0 |
| concepts[8].score | 0.18821698427200317 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q420 |
| concepts[8].display_name | Biology |
| concepts[9].id | https://openalex.org/C104317684 |
| concepts[9].level | 2 |
| concepts[9].score | 0.06144648790359497 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7187 |
| concepts[9].display_name | Gene |
| concepts[10].id | https://openalex.org/C170493617 |
| concepts[10].level | 2 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q208467 |
| concepts[10].display_name | Receptor |
| concepts[11].id | https://openalex.org/C42362537 |
| concepts[11].level | 3 |
| concepts[11].score | 0.0 |
| concepts[11].wikidata | https://www.wikidata.org/wiki/Q87099740 |
| concepts[11].display_name | Tyrosine kinase |
| concepts[12].id | https://openalex.org/C2779536868 |
| concepts[12].level | 4 |
| concepts[12].score | 0.0 |
| concepts[12].wikidata | https://www.wikidata.org/wiki/Q419940 |
| concepts[12].display_name | Dasatinib |
| keywords[0].id | https://openalex.org/keywords/ponatinib |
| keywords[0].score | 0.8121091723442078 |
| keywords[0].display_name | Ponatinib |
| keywords[1].id | https://openalex.org/keywords/medicine |
| keywords[1].score | 0.5685549974441528 |
| keywords[1].display_name | Medicine |
| keywords[2].id | https://openalex.org/keywords/post-hoc |
| keywords[2].score | 0.5382961630821228 |
| keywords[2].display_name | Post hoc |
| keywords[3].id | https://openalex.org/keywords/post-hoc-analysis |
| keywords[3].score | 0.5175687670707703 |
| keywords[3].display_name | Post-hoc analysis |
| keywords[4].id | https://openalex.org/keywords/mutation |
| keywords[4].score | 0.44518938660621643 |
| keywords[4].display_name | Mutation |
| keywords[5].id | https://openalex.org/keywords/oncology |
| keywords[5].score | 0.36307066679000854 |
| keywords[5].display_name | Oncology |
| keywords[6].id | https://openalex.org/keywords/internal-medicine |
| keywords[6].score | 0.32894736528396606 |
| keywords[6].display_name | Internal medicine |
| keywords[7].id | https://openalex.org/keywords/genetics |
| keywords[7].score | 0.20875108242034912 |
| keywords[7].display_name | Genetics |
| keywords[8].id | https://openalex.org/keywords/biology |
| keywords[8].score | 0.18821698427200317 |
| keywords[8].display_name | Biology |
| keywords[9].id | https://openalex.org/keywords/gene |
| keywords[9].score | 0.06144648790359497 |
| keywords[9].display_name | Gene |
| language | en |
| locations[0].id | doi:10.1016/s2152-2650(23)01134-5 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S186546955 |
| locations[0].source.issn | 2152-2650, 2152-2669 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 2152-2650 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Clinical Lymphoma Myeloma & Leukemia |
| locations[0].source.host_organization | https://openalex.org/P4310320990 |
| locations[0].source.host_organization_name | Elsevier BV |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320990 |
| locations[0].license | |
| locations[0].pdf_url | https://doi.org/10.1016/s2152-2650(23)01134-5 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Clinical Lymphoma Myeloma and Leukemia |
| locations[0].landing_page_url | https://doi.org/10.1016/s2152-2650(23)01134-5 |
| indexed_in | crossref |
| authorships[0].author.id | https://openalex.org/A5015101485 |
| authorships[0].author.orcid | https://orcid.org/0000-0002-8636-1071 |
| authorships[0].author.display_name | Jorge E. Cortés |
| authorships[0].countries | GE |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210142338 |
| authorships[0].affiliations[0].raw_affiliation_string | Georgia Cancer Center, Augusta, USA. |
| authorships[0].institutions[0].id | https://openalex.org/I4210142338 |
| authorships[0].institutions[0].ror | https://ror.org/0457d9w72 |
| authorships[0].institutions[0].type | nonprofit |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210142338 |
| authorships[0].institutions[0].country_code | GE |
| authorships[0].institutions[0].display_name | National Cancer Center of Georgia |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | Jorge Cortes |
| authorships[0].is_corresponding | False |
| authorships[0].raw_affiliation_strings | Georgia Cancer Center, Augusta, USA. |
| authorships[1].author.id | https://openalex.org/A5007755609 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-2987-1331 |
| authorships[1].author.display_name | Michael W. Deininger |
| authorships[1].countries | US |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I204308271, https://openalex.org/I4210117001 |
| authorships[1].affiliations[0].raw_affiliation_string | Versiti Blood Research Institute, Medical College of Wisconsin, Milwaukee, USA. |
| authorships[1].institutions[0].id | https://openalex.org/I204308271 |
| authorships[1].institutions[0].ror | https://ror.org/00qqv6244 |
| authorships[1].institutions[0].type | education |
| authorships[1].institutions[0].lineage | https://openalex.org/I204308271 |
| authorships[1].institutions[0].country_code | US |
| authorships[1].institutions[0].display_name | Medical College of Wisconsin |
| authorships[1].institutions[1].id | https://openalex.org/I4210117001 |
| authorships[1].institutions[1].ror | https://ror.org/02sjnfb25 |
| authorships[1].institutions[1].type | healthcare |
| authorships[1].institutions[1].lineage | https://openalex.org/I4210117001 |
| authorships[1].institutions[1].country_code | US |
| authorships[1].institutions[1].display_name | Versiti Blood Center of Wisconsin |
| authorships[1].author_position | middle |
| authorships[1].raw_author_name | Michael Deininger |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Versiti Blood Research Institute, Medical College of Wisconsin, Milwaukee, USA. |
| authorships[2].author.id | https://openalex.org/A5078634760 |
| authorships[2].author.orcid | |
| authorships[2].author.display_name | Elza Lomaia |
| authorships[2].countries | RU |
| authorships[2].affiliations[0].institution_ids | https://openalex.org/I3018698992 |
| authorships[2].affiliations[0].raw_affiliation_string | Almazov National Medical Research Centre, St. Petersburg, Russian Federation. |
| authorships[2].institutions[0].id | https://openalex.org/I3018698992 |
| authorships[2].institutions[0].ror | https://ror.org/03qepc107 |
| authorships[2].institutions[0].type | facility |
| authorships[2].institutions[0].lineage | https://openalex.org/I3018698992 |
| authorships[2].institutions[0].country_code | RU |
| authorships[2].institutions[0].display_name | Federal Almazov North-West Medical Research Centre |
| authorships[2].author_position | middle |
| authorships[2].raw_author_name | Elza Lomaia |
| authorships[2].is_corresponding | False |
| authorships[2].raw_affiliation_strings | Almazov National Medical Research Centre, St. Petersburg, Russian Federation. |
| authorships[3].author.id | https://openalex.org/A5051359342 |
| authorships[3].author.orcid | |
| authorships[3].author.display_name | Beatriz Moiraghi |
| authorships[3].countries | AR |
| authorships[3].affiliations[0].institution_ids | https://openalex.org/I4210103251 |
| authorships[3].affiliations[0].raw_affiliation_string | Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina. |
| authorships[3].institutions[0].id | https://openalex.org/I4210103251 |
| authorships[3].institutions[0].ror | https://ror.org/01bnyxq20 |
| authorships[3].institutions[0].type | healthcare |
| authorships[3].institutions[0].lineage | https://openalex.org/I4210103251 |
| authorships[3].institutions[0].country_code | AR |
| authorships[3].institutions[0].display_name | Hospital Ramos Mejía |
| authorships[3].author_position | middle |
| authorships[3].raw_author_name | Beatriz Moiraghi |
| authorships[3].is_corresponding | False |
| authorships[3].raw_affiliation_strings | Hospital Jose Maria Ramos Mejia, Buenos Aires, Argentina. |
| authorships[4].author.id | https://openalex.org/A5045109031 |
| authorships[4].author.orcid | |
| authorships[4].author.display_name | Maria Undurraga Sutton |
| authorships[4].countries | CL |
| authorships[4].affiliations[0].institution_ids | https://openalex.org/I4210098845 |
| authorships[4].affiliations[0].raw_affiliation_string | Hospital del Salvador, Santiago, Chile. |
| authorships[4].institutions[0].id | https://openalex.org/I4210098845 |
| authorships[4].institutions[0].ror | https://ror.org/00zrn3e14 |
| authorships[4].institutions[0].type | healthcare |
| authorships[4].institutions[0].lineage | https://openalex.org/I4210098845 |
| authorships[4].institutions[0].country_code | CL |
| authorships[4].institutions[0].display_name | Hospital del Salvador |
| authorships[4].author_position | middle |
| authorships[4].raw_author_name | Maria Undurraga Sutton |
| authorships[4].is_corresponding | False |
| authorships[4].raw_affiliation_strings | Hospital del Salvador, Santiago, Chile. |
| authorships[5].author.id | https://openalex.org/A5104174271 |
| authorships[5].author.orcid | |
| authorships[5].author.display_name | Carolina Pavlovsky |
| authorships[5].countries | AR |
| authorships[5].affiliations[0].institution_ids | https://openalex.org/I4210131024 |
| authorships[5].affiliations[0].raw_affiliation_string | Fundaleu, Buenos Aires, Argentina. |
| authorships[5].institutions[0].id | https://openalex.org/I4210131024 |
| authorships[5].institutions[0].ror | https://ror.org/02z3t5745 |
| authorships[5].institutions[0].type | nonprofit |
| authorships[5].institutions[0].lineage | https://openalex.org/I4210131024 |
| authorships[5].institutions[0].country_code | AR |
| authorships[5].institutions[0].display_name | Fundación para la Investigación, Docencia y Prevención del Cáncer |
| authorships[5].author_position | middle |
| authorships[5].raw_author_name | Carolina Pavlovsky |
| authorships[5].is_corresponding | False |
| authorships[5].raw_affiliation_strings | Fundaleu, Buenos Aires, Argentina. |
| authorships[6].author.id | https://openalex.org/A5078535679 |
| authorships[6].author.orcid | https://orcid.org/0000-0002-0834-9333 |
| authorships[6].author.display_name | Charles Chuah |
| authorships[6].countries | SG |
| authorships[6].affiliations[0].institution_ids | https://openalex.org/I2251586001, https://openalex.org/I4210126319 |
| authorships[6].affiliations[0].raw_affiliation_string | Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore. |
| authorships[6].institutions[0].id | https://openalex.org/I4210126319 |
| authorships[6].institutions[0].ror | https://ror.org/02j1m6098 |
| authorships[6].institutions[0].type | education |
| authorships[6].institutions[0].lineage | https://openalex.org/I165932596, https://openalex.org/I170897317, https://openalex.org/I4210126319 |
| authorships[6].institutions[0].country_code | SG |
| authorships[6].institutions[0].display_name | Duke-NUS Medical School |
| authorships[6].institutions[1].id | https://openalex.org/I2251586001 |
| authorships[6].institutions[1].ror | https://ror.org/036j6sg82 |
| authorships[6].institutions[1].type | healthcare |
| authorships[6].institutions[1].lineage | https://openalex.org/I2251586001 |
| authorships[6].institutions[1].country_code | SG |
| authorships[6].institutions[1].display_name | Singapore General Hospital |
| authorships[6].author_position | middle |
| authorships[6].raw_author_name | Charles Chuah |
| authorships[6].is_corresponding | False |
| authorships[6].raw_affiliation_strings | Singapore General Hospital, Duke-NUS Medical School, Singapore, Singapore. |
| authorships[7].author.id | https://openalex.org/A5029712912 |
| authorships[7].author.orcid | https://orcid.org/0000-0002-7207-6595 |
| authorships[7].author.display_name | Tomasz Sacha |
| authorships[7].countries | PL |
| authorships[7].affiliations[0].institution_ids | https://openalex.org/I126596746 |
| authorships[7].affiliations[0].raw_affiliation_string | Jagiellonian University Hospital in Krakow, Krakow, Poland. |
| authorships[7].institutions[0].id | https://openalex.org/I126596746 |
| authorships[7].institutions[0].ror | https://ror.org/03bqmcz70 |
| authorships[7].institutions[0].type | education |
| authorships[7].institutions[0].lineage | https://openalex.org/I126596746 |
| authorships[7].institutions[0].country_code | PL |
| authorships[7].institutions[0].display_name | Jagiellonian University |
| authorships[7].author_position | middle |
| authorships[7].raw_author_name | Tomasz Sacha |
| authorships[7].is_corresponding | False |
| authorships[7].raw_affiliation_strings | Jagiellonian University Hospital in Krakow, Krakow, Poland. |
| authorships[8].author.id | https://openalex.org/A5014346242 |
| authorships[8].author.orcid | https://orcid.org/0000-0001-7391-7168 |
| authorships[8].author.display_name | Jeffrey H. Lipton |
| authorships[8].countries | CA |
| authorships[8].affiliations[0].institution_ids | https://openalex.org/I2802654988 |
| authorships[8].affiliations[0].raw_affiliation_string | Princess Margaret Cancer Centre, Toronto, Canada. |
| authorships[8].institutions[0].id | https://openalex.org/I2802654988 |
| authorships[8].institutions[0].ror | https://ror.org/03zayce58 |
| authorships[8].institutions[0].type | healthcare |
| authorships[8].institutions[0].lineage | https://openalex.org/I1325899441, https://openalex.org/I2802654988 |
| authorships[8].institutions[0].country_code | CA |
| authorships[8].institutions[0].display_name | Princess Margaret Cancer Centre |
| authorships[8].author_position | middle |
| authorships[8].raw_author_name | Jeffrey H. Lipton |
| authorships[8].is_corresponding | False |
| authorships[8].raw_affiliation_strings | Princess Margaret Cancer Centre, Toronto, Canada. |
| authorships[9].author.id | https://openalex.org/A5006561610 |
| authorships[9].author.orcid | |
| authorships[9].author.display_name | James McCloskey |
| authorships[9].countries | US |
| authorships[9].affiliations[0].institution_ids | https://openalex.org/I4210148589 |
| authorships[9].affiliations[0].raw_affiliation_string | The John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, USA. |
| authorships[9].institutions[0].id | https://openalex.org/I4210148589 |
| authorships[9].institutions[0].ror | https://ror.org/04p5zd128 |
| authorships[9].institutions[0].type | healthcare |
| authorships[9].institutions[0].lineage | https://openalex.org/I4210148589 |
| authorships[9].institutions[0].country_code | US |
| authorships[9].institutions[0].display_name | Hackensack Meridian Health |
| authorships[9].author_position | middle |
| authorships[9].raw_author_name | James McCloskey |
| authorships[9].is_corresponding | False |
| authorships[9].raw_affiliation_strings | The John Theurer Cancer Center at Hackensack Meridian Health, Hackensack, USA. |
| authorships[10].author.id | https://openalex.org/A5052564121 |
| authorships[10].author.orcid | https://orcid.org/0000-0003-3238-4494 |
| authorships[10].author.display_name | Philippe Rousselot |
| authorships[10].countries | FR |
| authorships[10].affiliations[0].institution_ids | https://openalex.org/I195731000, https://openalex.org/I4210159263 |
| authorships[10].affiliations[0].raw_affiliation_string | Centre Hospitalier de Versailles University de Versailles Saint-Quentin-en-Yvelines, Paris, France. |
| authorships[10].institutions[0].id | https://openalex.org/I4210159263 |
| authorships[10].institutions[0].ror | https://ror.org/053evvt91 |
| authorships[10].institutions[0].type | healthcare |
| authorships[10].institutions[0].lineage | https://openalex.org/I4210159263 |
| authorships[10].institutions[0].country_code | FR |
| authorships[10].institutions[0].display_name | Centre Hospitalier de Versailles |
| authorships[10].institutions[1].id | https://openalex.org/I195731000 |
| authorships[10].institutions[1].ror | https://ror.org/03mkjjy25 |
| authorships[10].institutions[1].type | education |
| authorships[10].institutions[1].lineage | https://openalex.org/I195731000, https://openalex.org/I277688954 |
| authorships[10].institutions[1].country_code | FR |
| authorships[10].institutions[1].display_name | Université de Versailles Saint-Quentin-en-Yvelines |
| authorships[10].author_position | middle |
| authorships[10].raw_author_name | Philippe Rousselot |
| authorships[10].is_corresponding | False |
| authorships[10].raw_affiliation_strings | Centre Hospitalier de Versailles University de Versailles Saint-Quentin-en-Yvelines, Paris, France. |
| authorships[11].author.id | https://openalex.org/A5009003698 |
| authorships[11].author.orcid | https://orcid.org/0000-0002-0310-4206 |
| authorships[11].author.display_name | Gianantonio Rosti |
| authorships[11].countries | IT |
| authorships[11].affiliations[0].institution_ids | https://openalex.org/I4210097834, https://openalex.org/I4210153126 |
| authorships[11].affiliations[0].raw_affiliation_string | IRST/IRCCS "Dino Amadori,", Meldola (FC), Italy. |
| authorships[11].institutions[0].id | https://openalex.org/I4210153126 |
| authorships[11].institutions[0].ror | https://ror.org/04tfzc498 |
| authorships[11].institutions[0].type | healthcare |
| authorships[11].institutions[0].lineage | https://openalex.org/I4210153126 |
| authorships[11].institutions[0].country_code | IT |
| authorships[11].institutions[0].display_name | Istituti di Ricovero e Cura a Carattere Scientifico |
| authorships[11].institutions[1].id | https://openalex.org/I4210097834 |
| authorships[11].institutions[1].ror | https://ror.org/013wkc921 |
| authorships[11].institutions[1].type | facility |
| authorships[11].institutions[1].lineage | https://openalex.org/I4210097834, https://openalex.org/I4210153126 |
| authorships[11].institutions[1].country_code | IT |
| authorships[11].institutions[1].display_name | Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori |
| authorships[11].author_position | middle |
| authorships[11].raw_author_name | Gianantonio Rosti |
| authorships[11].is_corresponding | False |
| authorships[11].raw_affiliation_strings | IRST/IRCCS "Dino Amadori,", Meldola (FC), Italy. |
| authorships[12].author.id | https://openalex.org/A5074217417 |
| authorships[12].author.orcid | https://orcid.org/0000-0002-4988-2564 |
| authorships[12].author.display_name | Hugues de Lavallade |
| authorships[12].countries | GB |
| authorships[12].affiliations[0].institution_ids | https://openalex.org/I200166805 |
| authorships[12].affiliations[0].raw_affiliation_string | Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. |
| authorships[12].institutions[0].id | https://openalex.org/I200166805 |
| authorships[12].institutions[0].ror | https://ror.org/00j161312 |
| authorships[12].institutions[0].type | healthcare |
| authorships[12].institutions[0].lineage | https://openalex.org/I200166805 |
| authorships[12].institutions[0].country_code | GB |
| authorships[12].institutions[0].display_name | Guy's and St Thomas' NHS Foundation Trust |
| authorships[12].author_position | middle |
| authorships[12].raw_author_name | Hugues de Lavallade |
| authorships[12].is_corresponding | False |
| authorships[12].raw_affiliation_strings | Guy's and St Thomas' NHS Foundation Trust, London, United Kingdom. |
| authorships[13].author.id | https://openalex.org/A5113547507 |
| authorships[13].author.orcid | |
| authorships[13].author.display_name | Christine Rojas |
| authorships[13].countries | CL |
| authorships[13].affiliations[0].institution_ids | https://openalex.org/I3132875200 |
| authorships[13].affiliations[0].raw_affiliation_string | Centro de Investigaciones Clinicas Vina del Mar, Valparaíso, Chile. |
| authorships[13].institutions[0].id | https://openalex.org/I3132875200 |
| authorships[13].institutions[0].ror | https://ror.org/00txsqk22 |
| authorships[13].institutions[0].type | education |
| authorships[13].institutions[0].lineage | https://openalex.org/I3132875200 |
| authorships[13].institutions[0].country_code | CL |
| authorships[13].institutions[0].display_name | Viña del Mar University |
| authorships[13].author_position | middle |
| authorships[13].raw_author_name | Christine Rojas |
| authorships[13].is_corresponding | False |
| authorships[13].raw_affiliation_strings | Centro de Investigaciones Clinicas Vina del Mar, Valparaíso, Chile. |
| authorships[14].author.id | https://openalex.org/A5003294629 |
| authorships[14].author.orcid | https://orcid.org/0000-0001-9947-2371 |
| authorships[14].author.display_name | Anna Turkina |
| authorships[14].countries | RU |
| authorships[14].affiliations[0].institution_ids | https://openalex.org/I4210100648 |
| authorships[14].affiliations[0].raw_affiliation_string | National Medical Research Center for Hematology, Moscow, Russian Federation. |
| authorships[14].institutions[0].id | https://openalex.org/I4210100648 |
| authorships[14].institutions[0].ror | https://ror.org/015fskz95 |
| authorships[14].institutions[0].type | facility |
| authorships[14].institutions[0].lineage | https://openalex.org/I4210100648, https://openalex.org/I4210117042 |
| authorships[14].institutions[0].country_code | RU |
| authorships[14].institutions[0].display_name | National Medical Research Center for Hematology |
| authorships[14].author_position | middle |
| authorships[14].raw_author_name | Anna Turkina |
| authorships[14].is_corresponding | False |
| authorships[14].raw_affiliation_strings | National Medical Research Center for Hematology, Moscow, Russian Federation. |
| authorships[15].author.id | https://openalex.org/A5011529063 |
| authorships[15].author.orcid | https://orcid.org/0000-0003-3361-3981 |
| authorships[15].author.display_name | Moshe Talpaz |
| authorships[15].countries | US |
| authorships[15].affiliations[0].institution_ids | https://openalex.org/I27837315, https://openalex.org/I4210117557 |
| authorships[15].affiliations[0].raw_affiliation_string | Comprehensive Cancer Center, University of Michigan, Ann Arbor, USA. |
| authorships[15].institutions[0].id | https://openalex.org/I4210117557 |
| authorships[15].institutions[0].ror | https://ror.org/027t4kk23 |
| authorships[15].institutions[0].type | facility |
| authorships[15].institutions[0].lineage | https://openalex.org/I4210114445, https://openalex.org/I4210117557 |
| authorships[15].institutions[0].country_code | US |
| authorships[15].institutions[0].display_name | Michigan Center for Translational Pathology |
| authorships[15].institutions[1].id | https://openalex.org/I27837315 |
| authorships[15].institutions[1].ror | https://ror.org/00jmfr291 |
| authorships[15].institutions[1].type | education |
| authorships[15].institutions[1].lineage | https://openalex.org/I27837315 |
| authorships[15].institutions[1].country_code | US |
| authorships[15].institutions[1].display_name | University of Michigan |
| authorships[15].author_position | middle |
| authorships[15].raw_author_name | Moshe Talpaz |
| authorships[15].is_corresponding | False |
| authorships[15].raw_affiliation_strings | Comprehensive Cancer Center, University of Michigan, Ann Arbor, USA. |
| authorships[16].author.id | https://openalex.org/A5015789771 |
| authorships[16].author.orcid | https://orcid.org/0000-0002-2251-4032 |
| authorships[16].author.display_name | Michael J. Mauro |
| authorships[16].countries | US |
| authorships[16].affiliations[0].institution_ids | https://openalex.org/I1334819555 |
| authorships[16].affiliations[0].raw_affiliation_string | Memorial Sloan Kettering, New York, USA. |
| authorships[16].institutions[0].id | https://openalex.org/I1334819555 |
| authorships[16].institutions[0].ror | https://ror.org/02yrq0923 |
| authorships[16].institutions[0].type | healthcare |
| authorships[16].institutions[0].lineage | https://openalex.org/I1334819555 |
| authorships[16].institutions[0].country_code | US |
| authorships[16].institutions[0].display_name | Memorial Sloan Kettering Cancer Center |
| authorships[16].author_position | middle |
| authorships[16].raw_author_name | Michael Mauro |
| authorships[16].is_corresponding | False |
| authorships[16].raw_affiliation_strings | Memorial Sloan Kettering, New York, USA. |
| authorships[17].author.id | https://openalex.org/A5022975853 |
| authorships[17].author.orcid | |
| authorships[17].author.display_name | Vickie Lu |
| authorships[17].countries | US |
| authorships[17].affiliations[0].institution_ids | https://openalex.org/I4210140176 |
| authorships[17].affiliations[0].raw_affiliation_string | Takeda Development Center Americas, Inc., Lexington, USA. |
| authorships[17].institutions[0].id | https://openalex.org/I4210140176 |
| authorships[17].institutions[0].ror | https://ror.org/03bygaq51 |
| authorships[17].institutions[0].type | company |
| authorships[17].institutions[0].lineage | https://openalex.org/I4210140176, https://openalex.org/I44892455 |
| authorships[17].institutions[0].country_code | US |
| authorships[17].institutions[0].display_name | Takeda (United States) |
| authorships[17].author_position | middle |
| authorships[17].raw_author_name | Vickie Lu |
| authorships[17].is_corresponding | False |
| authorships[17].raw_affiliation_strings | Takeda Development Center Americas, Inc., Lexington, USA. |
| authorships[18].author.id | https://openalex.org/A5049967785 |
| authorships[18].author.orcid | |
| authorships[18].author.display_name | Alexander Vorog |
| authorships[18].countries | US |
| authorships[18].affiliations[0].institution_ids | https://openalex.org/I4210140176 |
| authorships[18].affiliations[0].raw_affiliation_string | Takeda Development Center Americas, Inc., Lexington, USA. |
| authorships[18].institutions[0].id | https://openalex.org/I4210140176 |
| authorships[18].institutions[0].ror | https://ror.org/03bygaq51 |
| authorships[18].institutions[0].type | company |
| authorships[18].institutions[0].lineage | https://openalex.org/I4210140176, https://openalex.org/I44892455 |
| authorships[18].institutions[0].country_code | US |
| authorships[18].institutions[0].display_name | Takeda (United States) |
| authorships[18].author_position | middle |
| authorships[18].raw_author_name | Alexander Vorog |
| authorships[18].is_corresponding | False |
| authorships[18].raw_affiliation_strings | Takeda Development Center Americas, Inc., Lexington, USA. |
| authorships[19].author.id | https://openalex.org/A5074115908 |
| authorships[19].author.orcid | https://orcid.org/0000-0002-1710-1794 |
| authorships[19].author.display_name | Jane F. Apperley |
| authorships[19].countries | GB |
| authorships[19].affiliations[0].institution_ids | https://openalex.org/I47508984 |
| authorships[19].affiliations[0].raw_affiliation_string | Imperial College London, London, United Kingdom |
| authorships[19].institutions[0].id | https://openalex.org/I47508984 |
| authorships[19].institutions[0].ror | https://ror.org/041kmwe10 |
| authorships[19].institutions[0].type | education |
| authorships[19].institutions[0].lineage | https://openalex.org/I47508984 |
| authorships[19].institutions[0].country_code | GB |
| authorships[19].institutions[0].display_name | Imperial College London |
| authorships[19].author_position | last |
| authorships[19].raw_author_name | Jane Apperley |
| authorships[19].is_corresponding | False |
| authorships[19].raw_affiliation_strings | Imperial College London, London, United Kingdom |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://doi.org/10.1016/s2152-2650(23)01134-5 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | CML-313 Post Hoc Analysis of Patient Responses by T315I Mutation Status From the 3-Year Update of the OPTIC Trial: A Dose-Optimization Study of 3 Starting Doses of Ponatinib |
| has_fulltext | True |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T11157 |
| primary_topic.field.id | https://openalex.org/fields/27 |
| primary_topic.field.display_name | Medicine |
| primary_topic.score | 0.9973999857902527 |
| primary_topic.domain.id | https://openalex.org/domains/4 |
| primary_topic.domain.display_name | Health Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2716 |
| primary_topic.subfield.display_name | Genetics |
| primary_topic.display_name | Chronic Lymphocytic Leukemia Research |
| related_works | https://openalex.org/W2182025991, https://openalex.org/W1973035946, https://openalex.org/W2087491399, https://openalex.org/W2177703973, https://openalex.org/W2111390454, https://openalex.org/W4383421632, https://openalex.org/W2995377144, https://openalex.org/W3014788916, https://openalex.org/W4378639993, https://openalex.org/W4383382866 |
| cited_by_count | 0 |
| locations_count | 1 |
| best_oa_location.id | doi:10.1016/s2152-2650(23)01134-5 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S186546955 |
| best_oa_location.source.issn | 2152-2650, 2152-2669 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 2152-2650 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Clinical Lymphoma Myeloma & Leukemia |
| best_oa_location.source.host_organization | https://openalex.org/P4310320990 |
| best_oa_location.source.host_organization_name | Elsevier BV |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://doi.org/10.1016/s2152-2650(23)01134-5 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Clinical Lymphoma Myeloma and Leukemia |
| best_oa_location.landing_page_url | https://doi.org/10.1016/s2152-2650(23)01134-5 |
| primary_location.id | doi:10.1016/s2152-2650(23)01134-5 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S186546955 |
| primary_location.source.issn | 2152-2650, 2152-2669 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 2152-2650 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Clinical Lymphoma Myeloma & Leukemia |
| primary_location.source.host_organization | https://openalex.org/P4310320990 |
| primary_location.source.host_organization_name | Elsevier BV |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320990 |
| primary_location.license | |
| primary_location.pdf_url | https://doi.org/10.1016/s2152-2650(23)01134-5 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Clinical Lymphoma Myeloma and Leukemia |
| primary_location.landing_page_url | https://doi.org/10.1016/s2152-2650(23)01134-5 |
| publication_date | 2023-08-30 |
| publication_year | 2023 |
| referenced_works_count | 0 |
| abstract_inverted_index | |
| cited_by_percentile_year | |
| countries_distinct_count | 11 |
| institutions_distinct_count | 20 |
| citation_normalized_percentile.value | 0.37393632 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |